NCT07217236 Proactive Risk Evaluation for Cardiac Implantable Electronic Device Strategy Using AI-ECG
| NCT ID | NCT07217236 |
| Status | Recruiting |
| Phase | — |
| Sponsor | National Defense Medical Center, Taiwan |
| Condition | Artificial Intelligence (AI) |
| Study Type | INTERVENTIONAL |
| Enrollment | 11,492 participants |
| Start Date | 2025-11-01 |
| Primary Completion | 2026-10-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 11,492 participants in total. It began in 2025-11-01 with a primary completion date of 2026-10-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to learn whether an artificial intelligence-enhanced electrocardiogram (AI-ECG) strategy improves timely intervention of patients requiring cardiac implantable electronic devices (CIEDs), compared with standard clinical care.
Eligibility Criteria
Inclusion Criteria: * At least one 12-lead ECG within 1 year Exclusion Criteria: * Diagnosis of sick sinus syndrome * Diagnosis of high-grade or complete atrioventricular block * Diagnosis of ventricular tachycardia or ventricular fibrillation * Post CIED implant * Heart rate below 40 beats per minute by 12-lead ECG
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07217236 clinical trial?
This trial is open to participants of all sexes, aged 65 Years or older, up to 90 Years, studying Artificial Intelligence (AI). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07217236 currently recruiting?
Yes, NCT07217236 is actively recruiting participants. Contact the research team at xup6fup0629@gmail.com for enrollment information.
Where is the NCT07217236 trial being conducted?
This trial is being conducted at Taipei, Taiwan.
Who is sponsoring the NCT07217236 clinical trial?
NCT07217236 is sponsored by National Defense Medical Center, Taiwan. The trial plans to enroll 11,492 participants.